 Allen S.W., Prasse K.W. and Mahaffey E.A.: “Cytologic Differentiation of Benign from Malignant Canine Mammary Tumors”; Vet Pathol, 1986, Vol 23, p. 649

(1)

BIBLIOGRAFIA:

 Aguggini G., Beghelli V., L.F. Giulio: “Fisiologia degli animali domestici con elementi di etologia” Ed. UTET, Seconda Edizione, 2006

 Allen S.W., Prasse K.W. and Mahaffey E.A.: “Cytologic Differentiation of Benign from Malignant Canine Mammary Tumors”; Vet Pathol, 1986, Vol 23, p. 649

 Barone R.: “Anatomia comparata dei mammiferi domestici”; Vol. 4°

Slancnologia, Edagricole

 Cassali et al.: “Consensus for the Diagnosis, Prognosis and Treatment of Canine Mammary Tumors”, Braz J Vet Pathol, 2011, Vol 4, pp 153-180

 Donnay I., Rauïs J., Devleeschouwer N., Wouters-Ballman P., Leclercq G., Verstegen J.: “Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs”, Am J Vet Res., 1995, Vol 56, pp 1188-94

 Feldman EC and Nelson RW: “Canine and Feline Endocrinology and Reproduction” Ed. Saunders, Third Edition, 2004

 Fossum T.W.: “Chirurgia dei piccoli animali”, Ed. Elsevier Masson, Terza Edizione, 2007

 Gilbertson S.R., Kurzman I.D., Zachrau R.E., Hurvitz A.I. and Black M.M.:

“Canine mammary epithelial neoplasms: Biologic implications of Morphologic

Characteristics assessed in 232 dogs”, Vet Pathol, 1983, Vol 20, pp 127-142

(2)

 Goldschmidt M., Pena L., Rasotto R. and Zappulli V.: “Classification and Grading of Canine Mammary Tumors”, Vet Pathol, 2011, Vol 48, p. 117

 Heller D.A., Clifford C.A., Goldschmidt M.H., Holt D.E., Shofer F.S., Smith A. and Sorenmo K.U.: “Cyclooxygenase-2 Expression is Associated with Histologic Tumor Type in Canine Mammary Carcinoma”, Vet Pathol, 2005, Vol 42, pp 776–780

 Hellmén E., Bergström R., Holmberg L., Spångberg I.-B., Hansson K. and Lindgren A.: “ Prognostic Factors in Canine Mammary Tumors: A Multivariate Study of 202 Consecutive Cases”, Vet Pathol, 1993, Vol 30, p. 20

 http://it.wikipedia.org/wiki/COX-2

 Karayannopoulou M.A., Koutinas F., Polizopoulou Z.S., Roubies N., Fytianou A., Saridomichelakis M.N., Kaldrymidou E.: “Total Serum Alkaline Phosphatase Activity in Dogs with Mammary Neoplasms: a Prospective Study on 79 Natural Cases”, Journal of Veterinary Medicine Series A, 2003, Vol 50, pp 501-505

 Karayannopoulou M., Kaldrymidou E., Constantinidis TC, Dessiris A.:

“Adjuvant post-operative chemotherapy in bitches with mammary cancer”, J Vet Med A Physiol Pathol Clin Med., 2001, Vol 48, pp 85-96

 Karayannopoulou M., Kaldrymidou E., Constantinidis T.C. and Dessiris A.:

“Histological Grading and Prognosis in Dogs with Mammary Carcinomas:

Application of a Human Grading Method”, J. Comp. Path., 2005, Vol. 133, pp 246–252

 Lavalle G.E., Bertagnolli A.C., Tavares W.L.F., and Cassali G.D.: “Cox-2 Expression in Canine Mammary Carcinomas: Correlation with Angiogenesis and Overall Survival”, Vet Pathol, 2009, Vol 46, pp 1275–1280

 MacEwen EG, Harvey HJ, Patnaik AK, Mooney S., Hayes A., Kurzman I.,

(3)

Hardy WD: “Evaluation of effects of levamisole and surgery on canine mammary cancer”, Jr. J Biol Response Mod., 1985, Vol 4, pp 418-26

 MacEwen E.G., Patnaik A.K., Harvey H.J., et al.: “Estrogen Receptors in Canine Mammary Tumors”, Cancer Res, 1982, Vol 42, pp 2255-2259

 Marconato L., Del Piero F.: “Oncologia medica dei piccoli animali” Poletto Editore, 2005

 Millanta F., Calandrella M., Bari G., Niccolini M., Vannozzi I., Poli A.:

“Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues”, Res Vet Sci., 2005, Vol 79, pp 225-32

 Millanta F., Citi S., Della Santa D., Porciani M., Poli A.: “COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers”, Breast Cancer Research and Treatment, 2006, Vol 98, pp 115-120

 Misdorp W. and Den Herder B.A.: “Bone Metastasis in Mammary Cancer: A Report of 10 Cases in the Female Dog and some comparison with human cases”, British Journal of Cancer, 1966, Vol 20, pp 496-503

 Misdorp W., Hart A.A.M.: “Prognostic Factors in Canine Mammary Cancer”

Journal of the National Cancer Institute, 1976, Vol 56, pp 779-786

 Morris J.S., Dobson J.M. and Bostock D.E.: “Use of tamoxifen in the control of canine mammary neoplasia” Veterinary Record, 1993, Vol 133, pp 539-542

 Moulton J.E., Taylor D.O.N., Dorn C.R. and Andersen A.C.: “Canine Mammary Tumors”, Pathol Vet, 1970, Vol 7, p. 289

 Muto T., Wakui S., Takahashi H., Maekawa S., Masaoka T., Ushigome S., and

Furusato M.: “p53 Gene Mutations Occurring in Spontaneous Benign and

Malignant Mammary Tumors of the Dog”, Vet Pathol, 2000, Vol 37, p. 248

(4)

 Nelson R.W., Couto C.G.:”Medicina interna del cane e del gatto” Ed. Elsevier Masson, Quarta Edizione, 2010

 Nieto A., Pérez-Alenza M.D., Del Castillo N., Tabanera E., Castaño M., Peña L.: “BRCA1 Expression in Canine Mammary Dysplasias and Tumours:

Relationship with Prognostic Variables” Journal of Comparative Pathology, 2003, Vol 128, pp 260–268

 Pérez Alenza M. Dolores, Pena Laura, Nieto Ana Isabel and Castano Maria:

“Clinical and pathological prognostic factors in canine mammary tumors”, Ann. Ist. Super. Sanità, 1997, Vol 33, pp 581-585

 Pérez Alenza M.D., Rutteman R. Gerard, Peña Laura, Beynen C. Anton, Cuesta Pedro: “Relation between Habitual Diet and Canine Mammary Tumors in a Case-Control Study”, Journal of Veterinary Internal Medicine, 1998, Vol 12, pp 132–139

 Pérez Alenza Dolores M., Tabanera Enrique, Peña Laura: “Inflammatory mammary carcinoma in dogs: 33 cases (1995–1999)” Journal of the American Veterinary Medical Association, 2001, Vol 219, pp 1110-1114

 Romanelli G.: “Oncologia del cane e del gatto” Ed. Elsevier Masson, 2007

 Rutteman R. Gerard, Cornelisse J. Cees, Dijkshoorn J. Nel, Poortman Jan and Misdorp Wim: “Flow Cytometric Analysis of DNA Ploidy in Canine Mammary Tumors” Cancer Res, 1988, Vol 48, p. 3411

 Sarli G., Preziosi R., Benazzi C., Castellani G., Marcato P.S.: “Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors”, J Vet Diagn Invest, 2002, Vol 14, pp 25–34

 Sartin EA, Barnes S., Toivio-Kinnucan M., Wright JC, Wolfe LG.:

“Heterogenic properties of clonal cell lines derived from canine mammary

(5)

carcinomas and sensitivity to tamoxifen and doxorubicin”, Anticancer Res., 1993, Vol 13, pp 229-36

 Schafer K.A., Kelly G., Schrader R., Griffith W.C., Muggenburg B.A., Tierney L.A., Lechner J.F., Janovitz E.B. and Hahn F.F.: “A Canine Model of Familial Mammary Gland Neoplasia”, Vet Pathol, 1998, Vol 35, p. 168

 Schneider R., Dorn C.R. and Taylor D.O.N.: “Factors Influencing Canine Mammary Cancer Development and Postsurgical Survival”, J Natl Cancer Inst, 1969, Vol 43, pp 1249-1261

 Sonnenschein G. Elizabeth, Glickman T. Lowrence, Goldschmidt H. Michael and McKee J. Linda: “Body Conformation, Diet, and Risk of Breast Cancer in Pet Dogs: A Case-Control Study”, Am. J. Epidemiol., 1991, Vol 133, pp 694- 703

 Sorenmo K.: “Canine mammary gland tumors”, Vet Clin Small Anim, 2003, Vol 33, pp 573–596

 Sorenmo U. Karin, Shofer S. Frances, Goldschmidt H. Michael: “Effect of Spaying and Timing of Spaying on Survival of Dogs with Mammary Carcinoma”, Journal of Veterinary Internal Medicine, 2000, Vol 14, pp 266–

270  Stockhaus C., Kohn B., Rudolph R., Brunnberg L., Giger U.: “Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma”, J Small Anim Pract., 1999, Vol 40, pp 326-31

 Tavasoly A., Golshahi H., Rezaie A., Farhadi M.: “Classification and grading of canine malignant mammary tumors”, Veterinary Research Forum, 2013, Vol 4, pp 25 – 30

 Taylor N. Glenn, Shabestari Lorraine, Williams Jerry, Mays Charles V., Angus

Walter, and McFarland Susan: “Mammary Neoplasia in a Closed Beagle

Colony”, Cancer Res, 1976, Vol 36, pp 2740-2743

(6)

 Teruo Itoh, Kazuyuki Uchida, Kenichi Ishikawa, Kiyotaka Kushima, Eiko Kushima, Hiroyoshi Tamada, Takashi Moritake, Hiroyuki Nakao and Hiroki Shii: “Clinicopathological Survey of 101 Canine mammary gland tumors:

differences between small-breed dogs and others”, J. Vet. Med. Sci., 2005, Vol 67, pp 345-347

 Withrow J. Stephen , Vail M. David: “Small Animal Clinical Oncology” Ed.

Saunders Elsevier, Fourth Edition, 2007

 Yamagami T, Kobayashi T, Takahashi K, Sugiyama M: “Prognosis for canine malignant mammary tumors based on TNM and histologic classification”, Journal of veterinary medical science, 1996, Vol 58, pp 1079-1083

 Yamagami T., Kobayashi T., Takahashi K., Sugiyama M.: “Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours”, Journal of Small Animal Practice, 1996, Vol 37, pp 462–

464  Zatloukal J., Lorenzová J., Tich˘F., Neãas A., Kecová H., Kohout P.: “Breed

and Age as Risk Factors for Canine Mammary Tumours”, Acta Vet. Brno,

2005, Vol 74, pp 103-109